These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3998534)

  • 1. [Myocardial ultrastructural changes and cardiac performance in valvular heart disease--a clinical study].
    Ozaki K
    Nihon Kyobu Geka Gakkai Zasshi; 1985 Feb; 33(2):147-60. PubMed ID: 3998534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of the relationship between cardiac functions, myocardial preservations and myocardial degenerations in valvular heart diseases].
    Beika M
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Nov; 34(11):1937-53. PubMed ID: 3819494
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrastructural evaluation of the effects of global ischemia and reperfusion on human myocardium.
    Schaper J; Schwarz F; Kittstein H; Kreisel E; Winkler B; Hehrlein FW
    Thorac Cardiovasc Surg; 1980 Oct; 28(5):337-42. PubMed ID: 6161432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial ultrastructural lesions in septic valvulopathies.
    Laky D; Cândea V; Popa A; Tintoiu I; Cândea TB
    Rom J Morphol Embryol; 1990; 36(3-4):185-7. PubMed ID: 2151287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and metabolic correlates of cell injury in the hypertrophied myocardium during valve replacement.
    Warner KG; Khuri SF; Kloner RA; Josa M; Dalecki-Chipperfield KM; Butler MD; Assousa SN; Lee SS; Barsamian EM; Seiler M
    J Thorac Cardiovasc Surg; 1987 May; 93(5):741-54. PubMed ID: 2952840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the efficacy of human heart protection during cardioplegia].
    Krymskiĭ LD; Artiukhina TV; Blagoveshchenskaia RP
    Arkh Patol; 1983; 45(1):17-25. PubMed ID: 6847399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Invasive cardiologic diagnosis in acquired heart defects].
    Rudolph W; Goppel L
    Med Klin; 1978 Jan; 73(3):106-8. PubMed ID: 146150
    [No Abstract]   [Full Text] [Related]  

  • 8. Energy loss for evaluating heart valve performance.
    Akins CW; Travis B; Yoganathan AP
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):820-33. PubMed ID: 18954618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Right ventricular performance in patients with valvular heart diseases following surgery].
    Ohteki H; Hashimoto A; Hayashi H; Koyanagi H; Suzuki S; Kimata S; Nakazawa M
    Kokyu To Junkan; 1985 Mar; 33(3):339-44. PubMed ID: 4012059
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical physiopathology of the heart].
    Kettler D
    Klin Anasthesiol Intensivther; 1976 Apr; (11):13-39. PubMed ID: 994448
    [No Abstract]   [Full Text] [Related]  

  • 11. [Morphology of myocardial biopsies and their clinical significance].
    Kunkel B; Schneider M; Kober G; Bussmann WD; Hopf R; Kaltenbach M
    Z Kardiol; 1982 Dec; 71(12):787-94. PubMed ID: 6891870
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of left ventricular performance and the structure of the myocardium by endomyocardial biopsy in heart valve diseases].
    Nitenberg A; Perennec J; Curien N; Richalet JP; Veyssiere F; Hatt PY; Laurent D
    Arch Mal Coeur Vaiss; 1979 Dec; 72(12):1286-95. PubMed ID: 120144
    [No Abstract]   [Full Text] [Related]  

  • 13. [Predictors influencing on the decision and optimal timing of operation for valvular heart disease (author's transl)].
    Shigenobu M; Tsui Y; Sunakawa M; Sugiyama A; Hirai R; Miyai Y; Moriyama S; Miyake K; Tsuji H; Ando A; Kurihara H; Kino K; Yoshida H; Kurita S; Senoo Y; Teramoto S
    Kyobu Geka; 1981 Jul; 34(7):504-9. PubMed ID: 7311243
    [No Abstract]   [Full Text] [Related]  

  • 14. [Can irreversible ventricular dysfunction be identified in patients with heart valve disease?].
    Delahaye JP; de Gevigney G
    Ann Cardiol Angeiol (Paris); 1994 Dec; 43(10):578-87. PubMed ID: 7864550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dye-dilution technique fof measurement or cardiac output during operation for valvular disease: the importance of injection site.
    Wiberg-Jorgensen F; Engell HC; Rygg IH
    Dan Med Bull; 1975 Jan; 22(1):4-9. PubMed ID: 1095313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiomyocyte in valvular cardiopathies. Comparative morphometry of myofibrils and mitochondria. Functional correlations].
    Chomette G; Auriol M; Luxereau P; Acar JC
    Arch Anat Cytol Pathol; 1991; 39(3):73-6. PubMed ID: 1929574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serial changes in cardiovascular dimensions and left ventricular function after surgery of valvular heart disease: a follow-up study by echocardiography].
    Toyosaki N; Shiina A; Hashimoto T; Yamasawa M; Suzuki O; Yaginuma T; Hosoda S; Harada M; Kimura S; Hasegawa T
    J Cardiol; 1987 Mar; 17(1):65-76. PubMed ID: 3429923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Echocardiographic evaluation of the serial changes in cardiac functions before and after surgery of valvular heart diseases and the left ventricular reserve by the dynamic exercise].
    Sano S
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Jan; 31(1):73-85. PubMed ID: 6854089
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myocardium in valvular cardiopathies. Ultrastructural and histoenzymological changes. Functional correlations].
    Chomette G; Acar JC; Luxereau P; Auriol M
    Ann Anat Pathol (Paris); 1976; 21(4-5):387-400. PubMed ID: 139835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative hemodynamics after insertion of Starr-Ewards ball-valve prostheses for acquired valvular heart disease.
    Fletcher JR; Ashworth HE; Shepard BM; Mills M
    J Thorac Cardiovasc Surg; 1974 Feb; 67(2):285-90. PubMed ID: 4811001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.